PT-141 10mg

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist studied for its interaction with central melanocortin signaling pathways. Research evaluates its receptor-binding properties and downstream neuroendocrine regulatory mechanisms in experimental systems.

FDA Disclaimer: The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The products offered are not intended to diagnose, treat, cure, or prevent any disease. All products are intended for laboratory research use only and are not for human consumption.